Risperidone Sustained Release Microsphere Composition

Patent No. EP3566696 (titled "Risperidone Sustained Release Microsphere Composition") was filed by Geneora Pharma Shijiazhuang on Apr 10, 2012. The application was issued on Oct 7, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
ALKERMES PHARMA IRELAND	Jul 7, 2021	ATKINS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Feb 9, 2023
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Feb 9, 2023
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Feb 6, 2023
Termination of the opposition proceedings with maintenance of patent
Nov 11, 2022
Brief communication - Opposition proceedings
Nov 11, 2022
Brief communication to applicant/representative
Nov 11, 2022
Communication of the registration of a transfer or change of name and/or address
Nov 2, 2022
(Electronic) Receipt
Nov 2, 2022
Annexes in respect of a client data request
Nov 2, 2022
Annexes in respect of a client data request
Nov 2, 2022
Letter accompanying subsequently filed items
Nov 2, 2022
Submission concerning a transfer of rights (proprietor)
Oct 26, 2022
Annex to the communication - opposition
Oct 26, 2022
Decision of the Opposition Division and instruction
Oct 26, 2022
Decision rejecting the opposition
Oct 26, 2022
Decision rejecting the opposition
Oct 26, 2022
Grounds for the decision (Annex) - opposition
Oct 26, 2022
Means of redress
Oct 26, 2022
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Oct 26, 2022
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Oct 26, 2022
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Oct 26, 2022
Provision of a copy of the minutes - opposition procedure
Oct 26, 2022
Provision of a copy of the minutes - opposition procedure
Oct 26, 2022
Scanned annex to a communication - opposition procedure
Oct 26, 2022
Transmittal of decision / summons - opposition
Oct 26, 2022
Transmittal of decision / summons - opposition
Oct 13, 2022
Information about the result of oral proceedings
Aug 18, 2022
Brief communication - Opposition proceedings
Aug 12, 2022
(Electronic) Receipt
Aug 12, 2022
Letter accompanying subsequently filed items
Aug 12, 2022
Written submission in preparation to/during oral proceedings
Aug 5, 2022
Brief communication - Opposition proceedings
Aug 2, 2022
(Electronic) Receipt
Aug 2, 2022
Letter accompanying subsequently filed items
Aug 2, 2022
Request for interpreters during oral proceedings
Apr 26, 2022
Notification concerning the date of oral proceedings
Apr 26, 2022
Notification concerning the date of oral proceedings
Feb 28, 2022
Advice of delivery
Feb 23, 2022
Advice of delivery
Feb 22, 2022
Annex to the communication - opposition
Feb 22, 2022
Information concerning oral proceedings
Feb 22, 2022
Transmittal of decision / summons - opposition
Feb 22, 2022
Transmittal of decision / summons - opposition
Dec 1, 2021
Brief communication - Opposition proceedings
Nov 23, 2021
(Electronic) Receipt
Nov 23, 2021
Citation in opposition procedure - 019
Nov 23, 2021
Consolidated list of cited opposition documents
Nov 23, 2021
Letter accompanying subsequently filed items
Nov 23, 2021
Letter regarding the opposition procedure (no time limit)
Nov 22, 2021
(Electronic) Receipt
Nov 22, 2021
Citation in opposition procedure - 019
Nov 22, 2021
Citation in opposition procedure - 020
Nov 22, 2021
Citation in opposition procedure - 021
Nov 22, 2021
Letter accompanying subsequently filed items
Nov 22, 2021
Reply of the patent proprietor to the notice(s) of opposition
Aug 23, 2021
Brief communication - Opposition proceedings
Aug 23, 2021
Communication concerning the filing of a power of attorney
Aug 23, 2021
Communication of amended entries concerning the representative
Aug 17, 2021
(Electronic) Receipt
Aug 17, 2021
Authorisation
Aug 17, 2021
Authorisation
Aug 17, 2021
Letter accompanying subsequently filed items
Aug 17, 2021
Submission concerning change of proprietor's representative
Aug 12, 2021
Communication concerning signing of documents
Aug 2, 2021
(Electronic) Receipt
Aug 2, 2021
Authorisation
Aug 2, 2021
Authorisation
Aug 2, 2021
Letter accompanying subsequently filed items
Aug 2, 2021
Submission concerning change of proprietor's representative
Jul 21, 2021
Communication of a notice of opposition and request to file observations
Jul 21, 2021
Notice of further oppositions to opponent(s)
Jul 13, 2021
Communication of a notice of opposition - first information to patent proprietor
Jul 7, 2021
(Electronic) Receipt
Jul 7, 2021
Citation in opposition procedure - 001
Jul 7, 2021
Citation in opposition procedure - 002
Jul 7, 2021
Citation in opposition procedure - 003
Jul 7, 2021
Citation in opposition procedure - 004
Jul 7, 2021
Citation in opposition procedure - 005
Jul 7, 2021
Citation in opposition procedure - 006
Jul 7, 2021
Citation in opposition procedure - 007
Jul 7, 2021
Citation in opposition procedure - 008
Jul 7, 2021
Citation in opposition procedure - 009
Jul 7, 2021
Citation in opposition procedure - 010
Jul 7, 2021
Citation in opposition procedure - 011
Jul 7, 2021
Citation in opposition procedure - 012
Jul 7, 2021
Citation in opposition procedure - 013
Jul 7, 2021
Citation in opposition procedure - 014
Jul 7, 2021
Citation in opposition procedure - 015
Jul 7, 2021
Citation in opposition procedure - 016
Jul 7, 2021
Citation in opposition procedure - 017
Jul 7, 2021
Citation in opposition procedure - 018
Jul 7, 2021
Notice of opposition
Jul 7, 2021
Notice of opposition
Oct 19, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 10, 2020
Decision to grant a European patent
Aug 31, 2020
(Electronic) Receipt
Aug 31, 2020
Filing of the translations of the claims
Aug 31, 2020
French translation of claims
Aug 31, 2020
German translation of the claims
Jun 22, 2020
Bibliographic data of the European patent application
Jun 22, 2020
Communication about intention to grant a European patent
Jun 22, 2020
Intention to grant (signatures)
Jun 22, 2020
Text intended for grant (clean copy)
Jun 22, 2020
Text intended for grant (version for approval)
May 20, 2020
Notice on debiting of fees
May 12, 2020
Examination started
Apr 1, 2020
(Electronic) Receipt
Apr 1, 2020
Letter accompanying subsequently filed items
Apr 1, 2020
Statement of non-availability of priority search results
Feb 28, 2020
Invitation to file a copy of search results(priority)
Feb 17, 2020
(Electronic) Receipt
Feb 17, 2020
Amended claims filed after receipt of (European) search report
Feb 17, 2020
Amended claims with annotations
Feb 17, 2020
Amendments received before examination
Feb 17, 2020
Letter accompanying subsequently filed items
Feb 5, 2020
Document concerning representation
Feb 5, 2020
Document concerning representation
Nov 18, 2019
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Nov 15, 2019
(Electronic) Receipt
Nov 15, 2019
Letter accompanying subsequently filed items
Nov 15, 2019
Written request for examination
Oct 18, 2019
Refund of fees
Oct 16, 2019
Communication regarding the transmission of the European search report
Oct 16, 2019
European search opinion
Oct 16, 2019
European search report
Oct 16, 2019
Information on Search Strategy
Oct 16, 2019
Notification of forthcoming publication
Oct 1, 2019
Search started
Jul 19, 2019
Communication to designated inventor
Jul 19, 2019
Communication to designated inventor
Jul 19, 2019
Communication to designated inventor
Jul 19, 2019
Communication to designated inventor
Jul 19, 2019
Communication to designated inventor
Jul 19, 2019
Communication to designated inventor
May 27, 2019
Abstract
May 27, 2019
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
May 27, 2019
Claims
May 27, 2019
Description
May 27, 2019
Designation of inventor
May 27, 2019
Drawings
May 27, 2019
Letter concerning search matters
May 27, 2019
Request for grant of a European patent
Nov 21, 2012
Priority document (electronically transmitted)

EP3566696

GENEORA PHARMA SHIJIAZHUANG

Application Number: EP19176691A
Filing Date: Apr 10, 2012
Status: Opposition Rejected; Feb 10, 2023
Publication Date: Oct 7, 2020
External Links: Slate, Register , Google Patents

IP Verse

Risperidone Sustained Release Microsphere Composition

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3566696